Hyperprolactinemia in Systemic Lupus Erythematosus
نویسندگان
چکیده
Prolactin is a dual function protein that functions both as a hormone as well as a cytokine (Ben-Jonathan et al., 1996). Prolactin is synthesized and secreted from pituitary gland and its primary role is to help initiate and maintain breast milk production in pregnant and nursing women (PRL prolactin). Prolactin is also synthesized and secreted from the cells of the immune system such as macrophages, natural killer cells, and Tand B-lymphocytes. Prolactin secreted from the immune cells act by stimulating the secretion of other cytokines as well asfunctions as a survival and growth and factor. The gene for prolactin is located in chromosome 6, the genetic locus is 6p 22.32. The prolactin gene is nearly 10Kb in size and the gene has 5 exons and 4 introns (Cooke et al., 1981). Mature human prolactin has 199 aminoacids and has molecular mass of approximately 23,000 Daltons. Prolactin on binding to its target prolactin receptor results in the activation JAK-STAT pathway. This augments the intracellular expression of IRF1 (Interferon regulatory factor 1) that cause transcription of IFN-γ which mediates the International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 5 (2017) pp. 2788-2792 Journal homepage: http://www.ijcmas.com
منابع مشابه
Codon 72 Polymorphism of p53 Gene and Hematologic Manifestations in Patients with Systemic Lupus Erythematosus
Background: Systemic lupus erythematosus is a systemic autoimmune disorder with unclear etiology. The importance of some genes in the development of systemic lupus erythematosus has been implicated. The gene polymorphism in codon 72 has attracted a lot of attention and its role in the occurrence or progression of many cancers and autoimmune diseases especially systemic lupus erythematosus has ...
متن کاملThyroid disorders, hyperprolactinemia and systemic lupus erythematosus activity
2014 Aim: The aim of this study was to determine the relationship between thyroid disorders and prolactin in patients with and without lupus activity. Patients & methods: Women with systemic lupus erythematosus (SLE) were evaluated for lupus activity. Serum tri-iodothyronine (T3), serum thyroxine (T4) and thyroid-stimulating hormone (TSH), anti-thyroid peroxidase (anti-TPO) anti-thyroglobulin (...
متن کاملA Case of Systemic Lupus Erythematosus
SUMMARY During the course of systemic lupus erythematosus in a 10 year-old girl, a go it er develo ped. Subc linical I ly pothyrnic.Jism was found, in addition rising titer of ant imicrosomal antibody and overt hypothyroidism after 6-week cessation of thyroxin tablet lead to the diagnosis of Hashimoto's thyroiditis. Antibodies directed to the thyroid may result in an autoimmune thyroiditis in...
متن کاملپرولاکتین سرم و فعالیت بیماری در مبتلایان به SLE: یک مطالعه مقطعی
Background: To evaluate the possibility that prolactin is involved in the pathogenesis and flare-up of systemic lupus erythematosus (SLE).Methods: In this cross-sectional study we determined serum prolactin levels in sixty (60) serum samples from sixty patients diagnosed with SLE by the criteria of the American College of Rheumatology (ACR). All patients were females between 13-64 years of age....
متن کاملCutaneous manifestations of systemic Lupus Erythematosus: A study from Ahwaz
Background: Systemic lupus erythematosus (SLE) is an autoimmune disease in which cutaneous lesions occur in 72%-85% of patients. Objective: This study was conducted to determine the pattern and incidence of skin lesions in SLE patients in Ahwaz. Patients and Methods: Thirty patients with SLE fulfilling the clinical and laboratory criteria of the American Rheumatism Association who were admitted...
متن کاملRare Association between Kikuchi's Disease and Systemic Lupus Erythematosus
Histiocytic necrotizing lymphadenitis or Kikuchi's disease is a rare, benign condition of unknown etiology, which is usually characterized by cervical lymphadenopathy and fever. This disease is rarely associated with systemic lupus erythematosus. Here we describe, for the first time in Iran, a patient who developed systemic lupus erythematosus about 3 years after the initial diagnosis of Kikuch...
متن کامل